Literature DB >> 27157301

Evolution and Developments in Instrumentation for Positron Emission Mammography.

Habib Zaidi1, Christopher Thompson2.   

Abstract

Molecular imaging using high-resolution PET instrumentation is now playing a pivotal role in basic and clinical research. The development of optimized detection geometries combined with high-performance detector technologies and compact designs of PET tomographs have become the goal of active research groups in academic and corporate settings. Significant progress has been achieved in the design of commercial PET instrumentation in the last decade allowing a spatial resolution of about 4 to 6 mm to be reached for whole-body imaging, about 2.4 mm for PET cameras dedicated for brain imaging, and submillimeter resolution for female breast, prostate, and small-animal imaging. In particular, significant progress has been made in the design of dedicated positron emission mammography (PEM) units. The initial concept suggested in 1993 consisted of placing 2 planar detectors capable of detecting the 511-keV annihilation photons in a conventional mammography unit. Since that time, many different design paths have been pursued and it will be interesting to see which technologies become the most successful in the future. This paper discusses recent advances in PEM instrumentation and the advantages and challenges of dedicated standalone and dual-modality imaging systems. Future opportunities and the challenges facing the adoption of PEM imaging instrumentation and its role in clinical and research settings are also addressed.
Copyright © 2009 Elsevier Inc. All rights reserved.

Year:  2009        PMID: 27157301     DOI: 10.1016/j.cpet.2009.12.002

Source DB:  PubMed          Journal:  PET Clin        ISSN: 1556-8598


  1 in total

1.  Suboptimal Sensitivity and Specificity of PET and Other Gross Imaging Techniques in Assessing Lymph Node Metastasis.

Authors:  Abass Alavi; Sean D Carlin; Thomas J Werner; Abdullah Al-Zaghal
Journal:  Mol Imaging Biol       Date:  2019-10       Impact factor: 3.488

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.